Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Non-Hodgkin's lymphomas (NHLs) are malignant neoplasms which are clinically and biologically diverse. Their incidence is constantly increasing and despite treatment advances, there is a need for novel targeted therapies. Here, we identified Lectin-like transcript 1 (LLT1) as a biomarker of germinal center (GC)-derived B-cell NHLs. LLT1 identifies GC B cells in reactive tonsils and lymph nodes and its expression is maintained in B-cell NHLs which derive from GC, including Burkitt lymphoma (BL), follicular lymphoma (FL), and GC-derived diffuse large B-cell lymphoma (DLBCL). We further show that LLT1 expression by tumors dampens natural killer (NK) cell functions following interaction with its receptor CD161, uncovering a potential immune escape mechanism. Our results pinpoint LLT1 as a novel biomarker of GC-derived B-cell NHLs and as a candidate target for innovative immunotherapies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570132 | PMC |
| http://dx.doi.org/10.1080/2162402X.2015.1026503 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience.
Support Care Cancer
July 2025
Department of Clinical Medicine and Surgery, Federico II University Medical School, Via Sergio Pansini, 5, Naples, 80131, Italy.
Febrile neutropenia (FN) is one of the most important clinical signs of infection, especially for older patients with indolent B cell non-Hodgkin lymphomas (iBC-NHLs) receiving frontline immune-chemotherapy with bendamustine-rituximab (BR). Data on the optimal strategy for infection prophylaxis from the start of chemotherapy until 1 month after the last cycle is scanty in this setting of patients, and for this reason, we carried out a multicentric retrospective study on vigorous primary anti-infectious prophylaxis consisting of lipegfilgrastim, trimethoprim-sulfamethoxazole, and acyclovir. From January 2017 to January 2022, 200 patients met the inclusion criteria and were enrolled in the final analysis.
View Article and Find Full Text PDFCD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHL.
Sci Rep
July 2025
UCLA AIDS Institute and David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
CD20 is a tetraspan membrane-bound protein vital for the development, activation, and differentiation of human B-cells. Non-Hodgkin lymphoma (NHL) is the most common hematological cancer in people living with (PLWH), and most B-cell NHLs express CD20. Extracellular vesicles (EVs) are nanosized vesicles released by cells into the extracellular environment.
View Article and Find Full Text PDFEZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma.
Sci Rep
June 2025
Department of Hematology, Faculty of Medicine, Çukurova University, Adana, Turkey.
EZH-2 overexpression or mutation is associated with various cancers, and there is a substantial academic literature on the role of EZH-2 and its mutant alleles in the pathogenesis of B-cell non-Hodgkin lymphomas (NHLs). The objective of the study was to examine the expression of EZH-2 in patients with low-grade NHL and to assess the effect of this expression on prognosis. The study included 140 pathologically diagnosed indolent NHL cases that met the established inclusion and exclusion criteria.
View Article and Find Full Text PDFThe Role of the Gut Microbiome in Non-Hodgkin Lymphoma (NHL): A Focus on Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Cutaneous T-Cell Lymphoma, and NK/T-Cell Lymphoma.
Cancers (Basel)
May 2025
Clinical Department of Oncodermatology, University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Non-Hodgkin lymphomas (NHLs) encompass a diverse group of neoplasms arising from the clonal proliferation of B-cell progenitors, T-cell progenitors, mature B-cells, mature T-cells, and natural killer (NK) cells. These malignancies account for over 90% of lymphoid neoplasms. The link between the gut microbiome and neoplasms has been extensively studied in recent years.
View Article and Find Full Text PDFRacial disparity in Non-Hodgkin Lymphoma: Parallel survival analysis with data from the DoD central cancer registry and SEER.
Ann Epidemiol
June 2025
Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Department of Preventive Medicine and Biostatistics, Uniformed Servic
Purpose: Barriers to health care access may contribute to the poorer survival of Black patients with Non-Hodgkin Lymphoma (NHL) than their White counterparts in the U.S. general population.
View Article and Find Full Text PDF